MTA1, a core member of the MTA family, is upregulated in numerous cancers and is associated with EMT, invasion, metastasis, angiogenesis, resistance to therapy, and poor prognosis in patients with cancer [19,20,21,22]. This evidence concerns the gene MTA1 and cancer.